NasdaqCM:MBOTMedical Equipment
Assessing Microbot Medical (MBOT) Valuation As LIBERTY Robotic System Advances Toward Full Market Release
Microbot Medical (MBOT) is coming into focus as its LIBERTY Endovascular Robotic System moves from a U.S. limited market release toward a planned full market rollout, supported by fresh exposure at a key industry conference.
See our latest analysis for Microbot Medical.
Recent trading reflects a mix of excitement and caution, with a 29.01% 7 day share price return and a modest 0.97% 90 day share price return sitting against a 5 year total shareholder return loss of 78.95%. Momentum therefore...